FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...